rs120074185
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM5PP3_StrongPP5_Very_Strong
The ENST00000155840.12(KCNQ1):c.1663C>A(p.Arg555Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000424 in 1,416,324 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R555C) has been classified as Pathogenic.
Frequency
Consequence
ENST00000155840.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNQ1 | NM_000218.3 | c.1663C>A | p.Arg555Ser | missense_variant | 13/16 | ENST00000155840.12 | NP_000209.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.1663C>A | p.Arg555Ser | missense_variant | 13/16 | 1 | NM_000218.3 | ENSP00000155840 | P1 | |
KCNQ1 | ENST00000335475.6 | c.1282C>A | p.Arg428Ser | missense_variant | 13/16 | 1 | ENSP00000334497 | |||
KCNQ1 | ENST00000496887.7 | c.1306C>A | p.Arg436Ser | missense_variant | 13/16 | 5 | ENSP00000434560 | |||
KCNQ1 | ENST00000646564.2 | c.1123C>A | p.Arg375Ser | missense_variant | 8/11 | ENSP00000495806 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000111 AC: 2AN: 179696Hom.: 0 AF XY: 0.0000210 AC XY: 2AN XY: 95188
GnomAD4 exome AF: 0.00000424 AC: 6AN: 1416324Hom.: 0 Cov.: 33 AF XY: 0.00000714 AC XY: 5AN XY: 699948
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Long QT syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Oct 23, 2023 | This missense variant replaces arginine with serine at codon 555 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Splice site prediction tools suggest that this variant may impact RNA splicing. This variant is found within a highly conserved region of C-terminal cytoplasmic domain. Rare nontruncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals suspected of having long QTS syndrome (PMID: 19716085, 32383558). This variant has also been observed either in the homozygous or compound heterozygous state in two unrelated individuals affected with autosomal recessive Jervell and Lange-Nielsen syndrome (PMID: 28606196, 32383558), indicating that this variant contributes to disease. Different missense variants occurring at the same codon, p.Arg555Cys and p.Arg555His, are known to be pathogenic (Clinvar variation ID 41835, 173188), indicating that arginine at this position is important for KCNQ1 protein function. This variant has been identified in 2/179696 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 17, 2023 | This sequence change replaces arginine, which is basic and polar, with serine, which is neutral and polar, at codon 555 of the KCNQ1 protein (p.Arg555Ser). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with long QT syndrome (PMID: 19716085, 32383558; Invitae). ClinVar contains an entry for this variant (Variation ID: 67046). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the p.Arg555 amino acid residue in KCNQ1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 2313012, 9386136, 14998624, 22949429, 23098067). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Congenital long QT syndrome Pathogenic:1Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 01, 2023 | proposed classification - variant undergoing re-assessment, contact laboratory - |
Long QT syndrome 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jul 17, 2023 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Dominant negative, loss of function and gain of function are known mechanisms of disease in this gene. Gain of function variants result exclusively in short QT syndrome 2 (MIM#609621), while dominant negative and loss of function variants can cause long QT syndrome 1 (LQTS, MIM#192500), familial atrial fibrillation 3 (MIM#607554) as well as Jervell and Lange-Nielsen syndrome (JLNS, MIM#220400) (OMIM, PMIDs: 19632626, 28438721). (I) 0108 - This gene is known to be associated with both recessive and dominant disease. JLNS is characterised by congenital, bilateral deafness and variable degrees of QT prolongation, and is the only condition caused by biallelic variants (PMID: 28438721). (I) 0112 - The condition associated with this gene has incomplete penetrance (OMIM, PMID: 20301308). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to serine. (I) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 (2 heterozygotes, 0 homozygotes). (SP) 0309 - Multiple alternative amino acid changes at the same position have been observed in gnomAD (v2) (highest allele count: 4 heterozygotes, 0 homozygotes). (I) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools and highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated KCNQ channel domain (DECIPHER). (I) 0701 - Other missense variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. The p.(Arg555Cys) and p.(Arg555His) variants have been classified as likely pathogenic and pathogenic by multiple clinical diagnostic laboratories (ClinVar; PMID: 19716085)). However, it should also be noted that the p.(Arg555Leu) variant has been classified as a VUS by Invitae. (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been classified as likely pathogenic or pathogenic by clinical diagnostic laboratories (GeneDx, VCGS) and has been identified in multiple individuals with Long QT and as homozygous or compound heterozygous in individuals with JLNS (PMIDs: 19716085, 28606196, 32383558). However, it should also be noted that this variant has been classified as a VUS by Invitae. (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 11, 2020 | Reported in an individual referred for LQTS genetic testing (Kapplinger et al., 2009); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); At the protein level, in silico analysis supports that this missense variant has a deleterious effect on protein structure/function; At the mRNA level, in silico analysis suggests this variant may impact gene splicing; in the absence of RNA/functional studies, the actual effect of this sequence change is unknown; This variant is associated with the following publications: (PMID: 15746441, 25854863, 19716085, 28606196, 32383558) - |
Cardiac arrhythmia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Sep 07, 2023 | This missense variant replaces arginine with serine at codon 555 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). Splice site prediction tools suggest that this variant may impact RNA splicing. This variant is found within a highly conserved region of C-terminal cytoplasmic domain. Rare nontruncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in two individuals suspected of having long QTS syndrome (PMID: 19716085, 32383558). This variant has also been observed either in the homozygous or compound heterozygous state in two unrelated individuals affected with autosomal recessive Jervell and Lange-Nielsen syndrome (PMID: 28606196, 32383558), indicating that this variant contributes to disease. Different missense variants occurring at the same codon, p.Arg555Cys and p.Arg555His, are known to be pathogenic (Clinvar variation ID 41835, 173188), indicating that arginine at this position is important for KCNQ1 protein function. This variant has been identified in 2/179696 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Based on the available evidence, this variant is classified as Likely Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at